| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 29,675 | 23,215 | 23,588 | | Cost of Revenue | 16,744 | 14,340 | 12,693 | | | Gross Profit | 12,931 | 8,875 | 10,895 | | | Operating Expenses | | Research Development | 4,676 | 4,218 | 4,015 | | Selling General and Administrative | 7,830 | 7,439 | 7,191 | | Non Recurring |
-
| 1,256 | 1,209 | | Others | 2,081 | 1,963 | 1,676 | | | | Total Operating Expenses |
-
| 14,876 | 14,091 | | | | Operating Income or Loss | (1,656) | (6,001) | (3,196) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26 | 119 | 208 | | Earnings Before Interest And Taxes | (1,630) | (5,882) | (2,988) | | Interest Expense | 405 | 2,521 | 2,578 | | Income Before Tax | (2,035) | (8,403) | (5,566) | | Income Tax Expense |
-
| 1,225 | (920) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,035) | (9,628) | (4,646) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,035) | (9,628) | (4,646) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,035) | ($9,628) | ($4,646) |
|
0.22% Nasdaq 
Income Statement
